TCR2 Therapeutics (TCRR) Stock Highlights

1.48 | +0%

2023-07-05 19:45:44

TCR2 Therapeutics Inc is a clinical-stage cell therapy company. It is engaged in developing a pipeline of novel T cell therapies for cancer patients suffering from solid tumors by powering the T cell receptor (TCR) with its proprietary, first-in-class TCR Fusion Construct T cells (TRuC-T cells). The companys TRuC-T cells specifically recognize and kill cancer cells by harnessing the entire TCR signaling complex, independent of human leukocyte antigens, which is effective in patients with solid tumors.

Statistics

Range Today

1.48 1.48

Volume Today 0

Range 1 Year

0.82 3.88

Volume 1 Year 99.42M

Range 3 Year

0.82 35.86

Volume 3 Year 360.53M

Range 10 Year

0.82 35.86

Volume 10 Year 388.51M

Highlights

Market Capitalization 58.11M (small)

Floating Shares 26.75M

Current Price 1.48

Price To Earnings -0.38

Price To Book 0.57

Earnings Per Share -4.2

Payout Ratio 0%

Performance

Latest 0%

1 Month -16.85%

3 Months -4.52%

6 Months +4.96%

1 Year -34.22%

3 Years -85.84%

5 Years -90.75%

10 Years -90.75%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.